These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 29183848

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome.
    Kang L, Fan B, Sun P, Huang W, Jin M, Wang Q, Gao Z.
    Acta Biomater; 2016 Oct 15; 44():341-54. PubMed ID: 27545812
    [Abstract] [Full Text] [Related]

  • 43. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
    Valla S, Hassan N, Vitale DL, Madanes D, Spinelli FM, Teixeira FCOB, Greve B, Espinoza-Sánchez NA, Cristina C, Alaniz L, Götte M.
    Int J Mol Sci; 2021 May 30; 22(11):. PubMed ID: 34070901
    [Abstract] [Full Text] [Related]

  • 44. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R, Liu Y, Gao H, Kuang Q, Zhang Q, Tang J, Fu H, Zhang Z, He Q.
    J Pharm Sci; 2015 Feb 30; 104(2):476-84. PubMed ID: 25256603
    [Abstract] [Full Text] [Related]

  • 45. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
    Liu D, Zhang Q, Wang J, Fan L, Zhu W, Cai D.
    Pharmazie; 2019 Feb 01; 74(2):83-90. PubMed ID: 30782256
    [Abstract] [Full Text] [Related]

  • 46. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers.
    Sahin B, Fife J, Parmar MB, Valencia-Serna J, Gul-Uludağ H, Jiang X, Weinfeld M, Lavasanifar A, Uludağ H.
    Biomaterials; 2014 Nov 01; 35(34):9382-94. PubMed ID: 25128374
    [Abstract] [Full Text] [Related]

  • 47. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M, Li P, Sheng N, Liu L, Pan H, Wang C, Cai L, Ma Y.
    ACS Appl Mater Interfaces; 2016 Apr 20; 8(15):9565-76. PubMed ID: 27007621
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T, Liu J, Zhao Z, Dong L, Cai H, Yin L, Zhou J, Huo M.
    J Control Release; 2016 Dec 10; 243():54-68. PubMed ID: 27702595
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation.
    Zhao MD, Cheng JL, Yan JJ, Chen FY, Sheng JZ, Sun DL, Chen J, Miao J, Zhang RJ, Zheng CH, Huang HF.
    Int J Nanomedicine; 2016 Dec 10; 11():1323-36. PubMed ID: 27099493
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.
    Lu S, Morris VB, Labhasetwar V.
    J Pharmacol Exp Ther; 2019 Sep 10; 370(3):902-910. PubMed ID: 30940690
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A, Höbel S, Heine C, Merz L, Kallendrusch S, Bechmann I, Merz F, Franke H, Aigner A.
    Drug Deliv Transl Res; 2017 Apr 10; 7(2):206-216. PubMed ID: 27334279
    [Abstract] [Full Text] [Related]

  • 60. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K, Gao Y, Yin S, Yao Y, Yu H, Wang G, Li J.
    Acta Biomater; 2021 Oct 15; 134():649-663. PubMed ID: 34289420
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.